SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $557,000 | +19.0% | 3,268 | -2.0% | 0.01% | 0.0% |
| Q3 2020 | $468,000 | -15.2% | 3,333 | -3.1% | 0.01% | -14.3% |
| Q2 2020 | $552,000 | +6.2% | 3,440 | -35.2% | 0.01% | -22.2% |
| Q1 2020 | $520,000 | +53.4% | 5,311 | +138.2% | 0.01% | +80.0% |
| Q2 2019 | $339,000 | +37.8% | 2,230 | +8.1% | 0.01% | +25.0% |
| Q1 2019 | $246,000 | +22.4% | 2,063 | +12.1% | 0.00% | 0.0% |
| Q4 2018 | $201,000 | -42.9% | 1,840 | -15.6% | 0.00% | -33.3% |
| Q3 2018 | $352,000 | +41.9% | 2,179 | +15.9% | 0.01% | +20.0% |
| Q2 2018 | $248,000 | +22.2% | 1,880 | -31.5% | 0.01% | +25.0% |
| Q1 2018 | $203,000 | -59.6% | 2,744 | -69.6% | 0.00% | -60.0% |
| Q4 2017 | $502,000 | +6.4% | 9,026 | -13.3% | 0.01% | 0.0% |
| Q3 2017 | $472,000 | +72.9% | 10,409 | +28.3% | 0.01% | +100.0% |
| Q2 2017 | $273,000 | – | 8,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |